Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Elke Langkopf"'
Autor:
Frank Himmelsbach, Ralf Lotz, Moh Tadayyon, Elke Langkopf, Herbert Nar, Norbert Hauel, Leo Thomas, Matthias Eckhardt, Michael Mark, Brian Guth
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:3158-3162
Systematic variations of the xanthine scaffold in close analogs of development compound BI 1356 led to the class of 3,5-dihydro-imidazo[4,5-d]pyridazin-4-ones which provided, after substituent screening, a series of highly potent DPP-4 inhibitors.
Publikováno v:
Tetrahedron Letters. 49:1931-1934
Two synthetic routes to the versatile 3,5-dihydro-imidazo[4,5-d]pyridazin-4-ones 2 and 5 have been developed that allow the production of multigram quantities without the need of any chromatographic purification. Broad and selective elaboration of th
Publikováno v:
Tetrahedron. 54:7203-7220
The first studies of the metal-catalyzed [5+2] cycloadditions of vinylcyclopropanes and alkenes are described. These reactions proceed with exceptional diastereoselectivity and in good to excellent yields. The effect of tether and substituent variati
Autor:
Dieter Schinzer, Elke. Langkopf
Publikováno v:
ChemInform. 25
Autor:
Dieter Schinzer, Elke. Langkopf
Publikováno v:
ChemInform. 26
Publikováno v:
ChemInform. 29
Publikováno v:
ChemInform. 29
The first studies of the metal-catalyzed [5+2] cycloadditions of vinylcyclopropanes and alkenes are described. These reactions proceed with exceptional diastereoselectivity and in good to excellent yields. The effect of tether and substituent variati
Autor:
Moh Tadayyon, Matthias Eckhardt, Herbert Nar, Ralf Lotz, Leo Thomas, Michael Mark, Elke Langkopf, Frank Himmelsbach, Brian Guth, Norbert Hauel
Publikováno v:
ChemInform. 39
Systematic variations of the xanthine scaffold in close analogs of development compound BI 1356 led to the class of 3,5-dihydro-imidazo[4,5-d]pyridazin-4-ones which provided, after substituent screening, a series of highly potent DPP-4 inhibitors.
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 325(1)
BI 1356 [proposed trade name ONDERO; (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione] is a novel dipeptidyl peptidase (DPP)-4 inhibitor under clinical development for the treatment
Autor:
Oliver Wissdorf, Elke Langkopf, Nadja Stadler, Ruediger Streicher, Werner Moreth, Alexander Pautsch
Publikováno v:
The Journal of biological chemistry. 283(14)
Disrupting the interaction between glycogen phosphorylase and the glycogen targeting subunit (G(L)) of protein phosphatase 1 is emerging as a novel target for the treatment of type 2 diabetes. To elucidate the molecular basis of binding, we have dete